Business Context and Reporting Period
Company: XpresSpa Group, Inc. (Note: Request metadata listed "XWELL, Inc.", but the filing identifies the registrant as XpresSpa Group, Inc.)
Filing Type: Form 8-K (Current Report)
Date: April 6, 2020
Event: Entry into a Material Definitive Agreement for a registered direct offering of common stock and pre-funded warrants.
Key Financial Metrics
- Gross Proceeds: Approximately $3.05 million (before deducting fees and expenses).
- Offering Price (Common Stock): $0.22 per share.
- Offering Price (Pre-Funded Warrants): $0.21 per warrant.
- Shares Issued: 12,418,179 shares of Common Stock.
- Pre-Funded Warrants Issued: 1,445,454 warrants (exercisable at $0.01 per share).
- Advisory Fee: 8% of aggregate gross proceeds payable to Palladium Capital Advisors, LLC.
- Outstanding Shares (Pre-Offering): 62,911,926.
- Outstanding Shares (Post-Offering, excluding warrant exercise): 75,330,105.
Note: The filing does not provide data on revenue, profit, cash flow, margins, or existing debt levels.
Material Changes
The primary material change is the dilution of existing shareholders due to the issuance of new equity. The total share count is expected to increase by approximately 19.7% (from ~62.9 million to ~75.3 million shares) immediately following the closing of the offering, assuming no exercise of pre-funded warrants.
Guidance, Outlook, and Risks
- Closing Date: Expected on or about April 8, 2020, subject to customary closing conditions.
- Use of Proceeds: The filing does not explicitly state the intended use of proceeds, though the offering is structured to raise capital.
- Ownership Caps: Pre-funded warrants were issued to prevent purchasers from beneficially owning more than 4.99% (or 9.99% in certain cases) of outstanding common stock immediately post-offering.
- Risks: The offering is subject to customary closing conditions. The filing includes standard legal disclaimers regarding the legality of the sale in various states.
Investor Verification Checklist
- Verify the final closing date and confirmation of the $3.05 million gross proceeds.
- Review the full Securities Purchase Agreement (Exhibit 10.1) for specific covenants or restrictions.
- Confirm the exact amount of the 8% advisory fee deducted from gross proceeds to determine net cash inflow.
- Monitor the exercise of pre-funded warrants, which could further increase the share count.
- Check subsequent filings for the specific allocation of the raised capital.